← Leaderboards
Xitiz Chamling
Johns Hopkins University
$1,024,474
Attributed
$1,024,474
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–24$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,024,474 · 2
By mechanism
R00$730,625 · 1
K99$293,849 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Donald J Zack$29,428,568
- Leslie Tung$12,122,938
- Ronald L Schnaar$20,308,382
- Peter A Calabresi$20,846,075
- Vincent W. Yang$29,529,911
Others in their field
Other Emerging Leaders on “Genome Editing”
- Dale Sandler · Social And Scientific Systems, Inc.$12,382,171
- William Raymond Lagor · Baylor College Of Medicine$10,790,231
- Benjamin E Deverman · Broad Institute, Inc.$10,165,764
- Yin Shen · University Of California, San Francisco$9,676,164
- Jesse M Engreitz · Stanford University$9,274,327
- William H. Peranteau · Children'S Hosp Of Philadelphia$7,624,302
Research focus
Genome EditingIncidenceEnvironmentGenesHuman Pluripotent Stem CellApoptosisBiologyAdvisory CommitteesEffective TherapyAxonHigh Throughput ScreeningAxon InjuryCellsChronicCoculture TechniquesCollaborationsBiometryCrispr InterferenceBlindnessAcuteDemyelinating DiseasesDemyelinationsCareer DevelopmentInflammation
Grant awards (6)
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$238,029
R00 · FY2024 · EY · contact PI
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$243,596
R00 · FY2023 · EY · contact PI
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$249,000
R00 · FY2022 · EY · contact PI
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$88,947
K99 · FY2021 · EY · contact PI
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$102,451
K99 · FY2020 · EY · contact PI
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells$102,451
K99 · FY2019 · EY · contact PI